FemTech Startups

CarpeDM is an exclusive dating platform combining human matchmaking with a video-first experience for singles seeking relationships with professional Black women. The service operates in major metropolitan areas across the United States, featuring verified member profiles, curated matching, and an 86% success rate.

1 investor

CELLECT develops nanomaterial-embedded menstrual products (tampons and pads) that non-invasively collect and preserve DNA from menstrual blood for screening of HPV, cervical cancer, and STDs. The collection system is compatible with existing diagnostic assays and targets women seeking an at-home alternative to Pap smears, including underserved communities.

1 investor

Celmatix Therapeutics developed a discovery portfolio focused on women's health, including therapeutic programs for infertility, endometriosis, and ovarian aging. The company's pipeline included an oral FSH receptor agonist, a JNK inhibitor, and AMH-targeting antibodies.

1 investor

Channel Medsystems (Cerene) develops easy-to-use medical devices for women's health, aimed at women and their gynecologists. The company operates in the gynecological medical device and femtech category.

1 investor

ChezLeon makes DP-Tx, a patented textile bra insert that uses differential pressure to gently massage tissue and keep lymphatic fluid moving, treating lymphoedema, mastitis, and post-breast-surgery swelling. The product is aimed at patients and healthcare professionals in cancer and breast care, and is listed on the Australian Register of Therapeutic Goods as a Class 1 Medical Device.

1 investor

Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.

1 investor

Chorus Health creates digital healthcare solutions using data, design, and technology to improve patient engagement and outcomes.

1 investor

Cirqle is developing a hormone-free, on-demand contraceptive that uses a molecule to reinforce the natural cervical mucus barrier and block sperm. The technology is in pre-clinical development and targets women seeking non-hormonal birth control options.

1 investor

Clever Girl Finance is a financial education platform providing free courses, mentoring, and community resources to help women build financial confidence and wealth. The platform covers budgeting, debt management, investing, and other personal finance topics for women.

1 investor

Comet Health is a digital fitness platform offering evidence-based programs for pelvic floor health, flexibility, and posture designed by physical therapists for home use. It serves women seeking rehabilitation and preventive care with guided video programs addressing conditions like diastasis recti, posture issues, and pre-natal preparation.

1 investor

Comma is a social enterprise creating sustainable period care products, including organic cotton tampons with compostable applicators, designed with privacy and security as core principles. The company reinvests revenue through a sister non-profit to support menstrual health education and product access in underserved communities globally.

1 investor

Conceivio offers an evidence-based digital program supporting users through fertility stages including trying to conceive, pregnancy, breastfeeding, and parenthood, with educational content aimed at improving the chances of natural conception. The product serves individuals on their fertility journey and delivers stage-specific guidance.

1 investor

Coralcone makes reusable menstrual cups marketed as a sustainable alternative to single-use period products such as pads, tampons and liners, with one cup replacing about five years of disposables. The company positions its product as a way to reduce ocean plastic waste and donates a portion of each sale to marine conservation.

1 investor

Corion Biotech develops therapeutic products for women's health using a "Cell Therapy without Cells" approach based on Placental Mesenchymal Stromal Cells (hPDMSCs) derived from human term placenta. Its programs target preeclampsia and epithelial cancers of ovarian and breast tissue.

1 investor

Cosma is a women's health and fertility company that designs, manufactures and distributes non-hormonal fertility products for the Indian market, positioned as an option between unassisted conception and IVF. Its offerings include Fertigen, a CDSCO-approved Class B medical device, and FertiLens, a digital fertility assessment platform, supported by a network of fertility specialists, diagnostic labs and partner clinics.

1 investor

CoTripper connects mothers through group travel experiences and community engagement. The platform facilitates organized trips and provides content for a community-focused audience.

1 investor

Couplet Care designs the Couplet Care Bassinet, a hospital bassinet developed through human-centered research to let mothers see, reach, and interact with newborns from their hospital beds. It serves hospital postnatal units and birthing families, focusing on maternal and infant safety in postpartum maternity care.

1 investor

Curio provides mental health care services focused on closing health equity gaps for women, leveraging a team with expertise in healthcare, regulatory affairs, and clinical research.

1 investor

Daisies is a women's health telemedicine app in Mexico offering a membership that provides access to female doctors across 20+ specialties, including gynecology, psychology, nutrition, general health, and training. It provides on-demand video consultations, digital prescriptions, a shared encrypted medical record, and clinical self-assessments, available 24/7 via mobile.</parameter> <parameter name="hq_country">MX

1 investor

Motherbeing offers a women's health app that combines an AI assistant ("Daleela") for medically-verified health guidance, cycle and period tracking, remote consultations with specialists in gynecology, dermatology, nutrition, and sexual health, and expert-led educational video programs. It serves women seeking to understand and care for their bodies.

1 investor

Dame designs and engineers sexual wellness products, including vibrators such as Eva and Fin, developed in-house to address disparities in sexual pleasure and satisfaction for women. The company also runs Dame Labs and works to reshape how sexual wellness and pleasure are understood.

1 investor

Dear Doc provides birth control access and reproductive health services for women in Singapore, delivered online in a discreet and judgment-free manner. The platform aims to make contraception affordable and accessible on women's own terms.

1 investor

1 investor

Dx4Life develops a genetic swab test that identifies a biomarker to guide the choice of hormone treatment for patients undergoing IVF, delivering results in under an hour. The test is aimed at fertility clinics to help match each patient with the right hormone treatment before in vitro fertilization.

1 investor